These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

714 related articles for article (PubMed ID: 8879346)

  • 1. Vascular hypertrophy and albumin permeability in a rat model combining hypertension and diabetes mellitus. Effects of calcium antagonism, angiotensin converting enzyme inhibition, and angiotensin II-AT1-receptor blockade.
    Hulthén UL; Cao Z; Rumble JR; Cooper ME; Johnston CI
    Am J Hypertens; 1996 Sep; 9(9):895-901. PubMed ID: 8879346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin converting enzyme inhibition and calcium antagonism attenuate streptozotocin-diabetes-associated mesenteric vascular hypertrophy independently of their hypotensive action.
    Cao Z; Hulthén UL; Allen TJ; Cooper ME
    J Hypertens; 1998 Jun; 16(6):793-9. PubMed ID: 9663919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular hypertrophy in diabetic spontaneously hypertensive rats: optimizing blockade of the renin-angiotensin system.
    Lassila M; Davis BJ; Allen TJ; Burrell LM; Cooper ME; Cao Z
    Clin Sci (Lond); 2003 Apr; 104(4):341-7. PubMed ID: 12653675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of effects of ACE inhibition with calcium channel blockade on renal disease in a model combining genetic hypertension and diabetes.
    Rumble JR; Doyle AE; Cooper ME
    Am J Hypertens; 1995 Jan; 8(1):53-7. PubMed ID: 7734098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular albumin permeability and hypertrophy in a rat model combining streptozotocin-induced diabetes and genetic hypertension.
    Hulthén UL; Rumble J; Cooper ME; Johnston CI
    J Hypertens; 1995 May; 13(5):529-33. PubMed ID: 7561010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistent cardiovascular effects of chronic renin-angiotensin system inhibition following withdrawal in adult spontaneously hypertensive rats.
    Paull JR; Widdop RE
    J Hypertens; 2001 Aug; 19(8):1393-402. PubMed ID: 11518847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved glucose metabolism following blockade of angiotensin converting enzyme but not angiotensin AT1 receptors.
    Chow L; De Gasparo M; Levens N
    Eur J Pharmacol; 1995 Aug; 282(1-3):77-86. PubMed ID: 7498292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Organ specificity of antihypertensive therapy on ocular albumin vascular clearance and albuminuria in the hypertensive diabetic rat.
    Gin T; Joon TL; Panagiotopoulos S; Cooper M; Taylor H; Jerums G
    Invest Ophthalmol Vis Sci; 1996 Feb; 37(2):281-9. PubMed ID: 8603832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of enalapril and valsartan in cyclosporine A-induced hypertension and nephrotoxicity in spontaneously hypertensive rats on high-sodium diet.
    Lassila M; Finckenberg P; Pere AK; Krogerus L; Ahonen J; Vapaatalo H; Nurminen ML
    Br J Pharmacol; 2000 Jul; 130(6):1339-47. PubMed ID: 10903974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Additive effects of cilnidipine and angiotensin II receptor blocker in preventing the progression of diabetic nephropathy in diabetic spontaneously hypertensive rats.
    Aritomi S; Niinuma K; Ogawa T; Konda T; Nitta K
    Clin Exp Nephrol; 2013 Feb; 17(1):41-50. PubMed ID: 23011292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of angiotensin-converting enzyme inhibitor and angiotensin type 1 receptor antagonist in deoxycorticosterone acetate-salt hypertensive mice lacking Ren-2 gene.
    Peng H; Carretero OA; Alfie ME; Masura JA; Rhaleb NE
    Hypertension; 2001 Mar; 37(3):974-80. PubMed ID: 11244026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of dietary salts on the cardiovascular effects of low-dose combination of ramipril and felodipine in spontaneously hypertensive rats.
    Mervaala EM; Malmberg L; Teräväinen TL; Laakso J; Vapaatalo H; Karppanen H
    Br J Pharmacol; 1998 Jan; 123(2):195-204. PubMed ID: 9489606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arterial responses in vitro and plasma digoxin immunoreactivity after losartan and enalapril treatments in experimental hypertension.
    Kalliovalkama J; Kähönen M; Tolvanen JP; Wu X; Voipio J; Pekki A; Doris PA; Ylitalo P; Pörsti I
    Pharmacol Toxicol; 2000 Jan; 86(1):36-43. PubMed ID: 10720105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of AT1 angiotensin-receptor blockade on structure and function of small arteries in SHR.
    Li JS; Sharifi AM; Schiffrin EL
    J Cardiovasc Pharmacol; 1997 Jul; 30(1):75-83. PubMed ID: 9268224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of angiotensin II and bradykinin in experimental diabetic nephropathy. Functional and structural studies.
    Allen TJ; Cao Z; Youssef S; Hulthen UL; Cooper ME
    Diabetes; 1997 Oct; 46(10):1612-8. PubMed ID: 9313758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelial dysfunction and salt-sensitive hypertension in spontaneously diabetic Goto-Kakizaki rats.
    Cheng ZJ; Vaskonen T; Tikkanen I; Nurminen K; Ruskoaho H; Vapaatalo H; Muller D; Park JK; Luft FC; Mervaala EM
    Hypertension; 2001 Feb; 37(2 Pt 2):433-9. PubMed ID: 11230314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of AT1 receptors in permeability of the blood-brain barrier in diabetic hypertensive rats.
    Awad AS
    Vascul Pharmacol; 2006 Sep; 45(3):141-7. PubMed ID: 16959546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute renal hemodynamic effects of ACE inhibition in diabetic hyperfiltration: role of kinins.
    Komers R; Cooper ME
    Am J Physiol; 1995 Apr; 268(4 Pt 2):F588-94. PubMed ID: 7733315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of dual angiotensin converting enzyme/neutral endopeptidase inhibition, angiotensin converting enzyme inhibition, or AT1 antagonism on coronary microvasculature in spontaneously hypertensive rats.
    Pu Q; Larouche I; Schiffrin EL
    Am J Hypertens; 2003 Nov; 16(11 Pt 1):931-7. PubMed ID: 14573331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of the renin-angiotensin pathway through enzyme inhibition and specific receptor blockade in pacing-induced heart failure: II. Effects on myocyte contractile processes.
    Spinale FG; Mukherjee R; Iannini JP; Whitebread S; Hebbar L; Clair MJ; Melton DM; Cox MH; Thomas PB; de Gasparo M
    Circulation; 1997 Oct; 96(7):2397-406. PubMed ID: 9337216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.